AI-Powered. Expert-Tailored.
Clarity for Complex IP, R&D, and Scientific Decisions.
We help leaders move critical decisions forward through structured analysis, expert insight, and technology-supported delivery, providing evidence and direction with speed and confidence.
50+ Global Enterprises Count on Evalueserve IP and R&D











Seminar in Seoul: From Patents to Profits: Real Cases of IP Monetization Success
Where We Focus
Drive Growth with Strategic IP and R&D Synergy.
From strategy to execution, delivering services that accelerate innovation and market success.
Strengthen Your
IP Strategy & Portfolio Positioning
Assess portfolio strength, competitive positioning to maximize IP value and strategic advantage.
Accelerate Your
R&D & Innovation
Pipeline
Evidence-based insights to guide R&D pipelines, ecosystem, and technology investments.
Navigate Complex
Scientific & Regulatory Pathways
Structured evaluation of evidence, safety, and regulatory strategy.
Optimize Your Processes With
AI-Assisted Workflows
Streamlined patent searches, competitive insights, and innovation scouting powered by AI.
Awards & Recognition
Recognized for "strength in domain-specific AI" *
* Chartis






eBook
How Can You Mitigate Risks in Medical Device Development
Learn how to navigate safety challenges in medical device development with trusted experts.
Success Story
Driving Revenue with Precision: AI-Assisted Patent Licensing Workflow
Discover how a global technology leader streamlined patent licensing with Evalueserve.
Our Clients
Success Stories.
Strategic Patentability Enhancement for a Manufacturing Leader
Sustainable Innovation in Polymer Production
Enhancing Chemical Safety and Compliance Through Strategic Collaboration
- SWIPE
Related Resources
Latest Insights from the IP and R&D World.

IP Follows Value: Your Portfolio Isn’t the Strategy
IP follows a value chain where impact is determined not by portfolio size but by how effectively organizations manage invention, protection, deployment, monetization, and defense to capture real business value.

Why Toxicology Cannot Afford AI Hype
Why Toxicology cannot afford AI hype: explore how scientific judgment, regulatory expectations, and data complexity shape responsible AI adoption in safety assessment.

6G Is Not an Upgrade. It’s a Reinvention of the IP Economy
6G Is Not an Upgrade — it’s a reinvention of the IP economy. Explore how sensing, AI, and new industry entrants are reshaping SEP licensing before 2030 commercialization begins.

Beyond the Battery: 5 Tech Trends Reshaping Fleet Economics
What comes Beyond the Battery? For C-suite fleet leaders, the answer is $32B in platform consolidation, V2G revenue, and AI that cuts costs by 40%. Here are the 5 trends that matter most.
- SWIPE
About Us
Are You Driven to Deliver?
At Evalueserve, we're committed to driving world-moving outcomes. We're building a high-performing, outcome driven culture that's made stronger by its diverse perspectives and global footprint.